Cargando…

Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores

Polygenic Risk Scores (PRS) for AD offer unique possibilities for reliable identification of individuals at high and low risk of AD. However, there is little agreement in the field as to what approach should be used for genetic risk score calculations, how to model the effect of APOE, what the optim...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonenko, Ganna, Baker, Emily, Stevenson-Hoare, Joshua, Sierksma, Annerieke, Fiers, Mark, Williams, Julie, de Strooper, Bart, Escott-Price, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302739/
https://www.ncbi.nlm.nih.gov/pubmed/34301930
http://dx.doi.org/10.1038/s41467-021-24082-z
_version_ 1783726934498213888
author Leonenko, Ganna
Baker, Emily
Stevenson-Hoare, Joshua
Sierksma, Annerieke
Fiers, Mark
Williams, Julie
de Strooper, Bart
Escott-Price, Valentina
author_facet Leonenko, Ganna
Baker, Emily
Stevenson-Hoare, Joshua
Sierksma, Annerieke
Fiers, Mark
Williams, Julie
de Strooper, Bart
Escott-Price, Valentina
author_sort Leonenko, Ganna
collection PubMed
description Polygenic Risk Scores (PRS) for AD offer unique possibilities for reliable identification of individuals at high and low risk of AD. However, there is little agreement in the field as to what approach should be used for genetic risk score calculations, how to model the effect of APOE, what the optimal p-value threshold (pT) for SNP selection is and how to compare scores between studies and methods. We show that the best prediction accuracy is achieved with a model with two predictors (APOE and PRS excluding APOE region) with pT<0.1 for SNP selection. Prediction accuracy in a sample across different PRS approaches is similar, but individuals’ scores and their associated ranking differ. We show that standardising PRS against the population mean, as opposed to the sample mean, makes the individuals’ scores comparable between studies. Our work highlights the best strategies for polygenic profiling when assessing individuals for AD risk.
format Online
Article
Text
id pubmed-8302739
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83027392021-08-12 Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores Leonenko, Ganna Baker, Emily Stevenson-Hoare, Joshua Sierksma, Annerieke Fiers, Mark Williams, Julie de Strooper, Bart Escott-Price, Valentina Nat Commun Article Polygenic Risk Scores (PRS) for AD offer unique possibilities for reliable identification of individuals at high and low risk of AD. However, there is little agreement in the field as to what approach should be used for genetic risk score calculations, how to model the effect of APOE, what the optimal p-value threshold (pT) for SNP selection is and how to compare scores between studies and methods. We show that the best prediction accuracy is achieved with a model with two predictors (APOE and PRS excluding APOE region) with pT<0.1 for SNP selection. Prediction accuracy in a sample across different PRS approaches is similar, but individuals’ scores and their associated ranking differ. We show that standardising PRS against the population mean, as opposed to the sample mean, makes the individuals’ scores comparable between studies. Our work highlights the best strategies for polygenic profiling when assessing individuals for AD risk. Nature Publishing Group UK 2021-07-23 /pmc/articles/PMC8302739/ /pubmed/34301930 http://dx.doi.org/10.1038/s41467-021-24082-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Leonenko, Ganna
Baker, Emily
Stevenson-Hoare, Joshua
Sierksma, Annerieke
Fiers, Mark
Williams, Julie
de Strooper, Bart
Escott-Price, Valentina
Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
title Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
title_full Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
title_fullStr Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
title_full_unstemmed Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
title_short Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
title_sort identifying individuals with high risk of alzheimer’s disease using polygenic risk scores
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302739/
https://www.ncbi.nlm.nih.gov/pubmed/34301930
http://dx.doi.org/10.1038/s41467-021-24082-z
work_keys_str_mv AT leonenkoganna identifyingindividualswithhighriskofalzheimersdiseaseusingpolygenicriskscores
AT bakeremily identifyingindividualswithhighriskofalzheimersdiseaseusingpolygenicriskscores
AT stevensonhoarejoshua identifyingindividualswithhighriskofalzheimersdiseaseusingpolygenicriskscores
AT sierksmaannerieke identifyingindividualswithhighriskofalzheimersdiseaseusingpolygenicriskscores
AT fiersmark identifyingindividualswithhighriskofalzheimersdiseaseusingpolygenicriskscores
AT williamsjulie identifyingindividualswithhighriskofalzheimersdiseaseusingpolygenicriskscores
AT destrooperbart identifyingindividualswithhighriskofalzheimersdiseaseusingpolygenicriskscores
AT escottpricevalentina identifyingindividualswithhighriskofalzheimersdiseaseusingpolygenicriskscores